Obtaining extensive in- and at-line input and output analytics combined with machine learning to improve predictive CQA
Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies
Single Particle Analyzer for high-throughput and high-content characterization of Nanoparticle-based RNA Therapy
Automation and Control of a Precipitation-based Continuous Downstream Process for High Titer Products